Employment AgreementEmployment Agreement • July 26th, 2021 • uniQure N.V. • Pharmaceutical preparations
13.2. Termination 14 13.3. Severance Generally 14 13.4. Severance on a Change of Control 15 13.5. Release from Work (Garden Leave) 17 14. Work Equipment and Obligation to Return Work Equipment 18 15. Working Time 18 15.1. General 18 15.2. Additional Work 18 16. Vacation 19 17. Public Holidays and Short Absences 19 17.1. Public Holidays 19 17.2. Short Absences 20 18. Incapacity to Work and Insurances 20 18.1. Medical Certificate 20 18.2. Salary in case of Employee’s Incapacity to Work 20 18.3. Occupational and Non-occupational Accidents 21 18.4. Health Insurance (Illness) 21 18.5. Pension Plan 21 19. Intellectual Property Rights and Work Results 22 20. Data Protection 23 21. Non-Competition and Non-Solicitation 23 21.1. General 23 21.2. Non-Competition during Employment 24 21.3. Post-Contractual Non-Competition 24 21.4. Post-Contractual Non-Solicitation 25 21.5. Penalty 25 22. Confidentiality 26
= Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. SALE AND...Sale and Purchase Agreement • July 26th, 2021 • uniQure N.V. • Pharmaceutical preparations • New York
This SHARE PURCHASE AGREEMENT (this “Agreement”) dated as of June 21, 2021 (the “Agreement Date”) is made and entered into by and among uniQure N.V., a public company with limited liability (naamloze vennootschap) formed under the laws of the Netherlands and registered with the Dutch trade register under number 54385229 (“Purchaser”); all shareholders of Corlieve Therapeutics SAS, a société par actions simplifiée formed under the laws of France (“Corlieve” or the “Company”), party hereto acting severally and not jointly (non solidairement) for the purposes hereof (“Sellers” and each, individually, a “Seller”); and the Holder Representative hereunder (collectively, the “Parties”), in presence of Corlieve for purposes of Section 4.
EMPLOYMENT AGREEMENT PURSUANT TO SECTION 7:610 (et seq.) of the Dutch Civil Code (DCC) June 15, 2021Employment Agreement • July 26th, 2021 • uniQure N.V. • Pharmaceutical preparations
May 17, 2021 Pierre Caloz RE: Side Letter Agreement re Equity Grants Dear Pierre,Side Letter Agreement • July 26th, 2021 • uniQure N.V. • Pharmaceutical preparations
Subject to Board of Directors approval at the next regularly scheduled uniQure N.V. Board meeting after the execution of this Agreement and subject to the commencement of employment pursuant to your employment agreement with uniQure biopharma B.V., uniQure N.V. (the “Company”) agrees to grant you:
